![PS-218 Developing A Safer Dosing Regimen Of Amikacin In Preterm Infants | Archives of Disease in Childhood PS-218 Developing A Safer Dosing Regimen Of Amikacin In Preterm Infants | Archives of Disease in Childhood](https://adc.bmj.com/content/archdischild/99/Suppl_2/A191.2/F1.large.jpg?width=800&height=600&carousel=1)
PS-218 Developing A Safer Dosing Regimen Of Amikacin In Preterm Infants | Archives of Disease in Childhood
![Jan De Waele MD on Twitter: "IsabelSpriet on #amikacin dosing in #ER patients - 15 vs 25 mg/kg #IFAD2017 @drPaulElbers @jasonroberts_pk https://t.co/SwgpVzOeho" / Twitter Jan De Waele MD on Twitter: "IsabelSpriet on #amikacin dosing in #ER patients - 15 vs 25 mg/kg #IFAD2017 @drPaulElbers @jasonroberts_pk https://t.co/SwgpVzOeho" / Twitter](https://pbs.twimg.com/media/DPTZ-UwXkAExbGb.jpg:large)
Jan De Waele MD on Twitter: "IsabelSpriet on #amikacin dosing in #ER patients - 15 vs 25 mg/kg #IFAD2017 @drPaulElbers @jasonroberts_pk https://t.co/SwgpVzOeho" / Twitter
![PDF] Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. | Semantic Scholar PDF] Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e64712fb8be6e8e996d4bd501cf5cbfb9b5f1972/5-Table4-1.png)